Medicinal and recreational marijuana use by patients infected with HIV
- PMID:15142352
- DOI: 10.1089/108729104323038892
Medicinal and recreational marijuana use by patients infected with HIV
Abstract
The goal of this study was to describe and compare the prevalence, predictors and patterns of marijuana use, specifically medicinal marijuana use among patients with HIV in Ontario, Canada. Any marijuana use in the year prior to interview and self-defined medicinal use were evaluated. A cross-sectional multicenter survey and retrospective chart review were conducted between 1999 and 2001 to evaluate overall drug utilization in HIV, including marijuana use. HIV-positive adults were identified through the HIV Ontario Observational Database (HOOD), 104 consenting patients were interviewed. Forty-three percent of patients reported any marijuana use, while 29% reported medicinal use. Reasons for use were similar by gender although a significantly higher number of women used marijuana for pain management. Overall, the most commonly reported reason for medicinal marijuana use was appetite stimulation/weight gain. Whereas male gender and history of intravenous drug use were predictive of any marijuana use, only household income less than $20,000 CDN was associated with medicinal marijuana use. Age, gender, HIV clinical status, antiretroviral use, and history of intravenous drug use were not significant predictors of medicinal marijuana use. Despite the frequency of medicinal use, minimal changes in the pattern of marijuana use upon HIV diagnosis were reported with 80% of current medicinal users also indicating recreational consumption. Although a large proportion of patients report medicinal marijuana use, overlap between medical and recreational consumption is substantial. The role of poverty in patient choice of medicinal marijuana despite access to care and the large proportion of women using marijuana for pain constitute areas for further study.
Similar articles
- A longitudinal investigation of the association between cannabis use and alcohol use among people living with HIV.Wardell JD, Shuper PA, Hendershot CS.Wardell JD, et al.Drug Alcohol Depend. 2018 Dec 1;193:7-13. doi: 10.1016/j.drugalcdep.2018.08.026. Epub 2018 Oct 6.Drug Alcohol Depend. 2018.PMID:30321740
- Medicinal and recreational marijuana use among HIV-infected women in the Women's Interagency HIV Study (WIHS) cohort, 1994-2010.Dʼsouza G, Matson PA, Grady CD, Nahvi S, Merenstein D, Weber KM, Greenblatt R, Burian P, Wilson TE.Dʼsouza G, et al.J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):618-26. doi: 10.1097/QAI.0b013e318273ab3a.J Acquir Immune Defic Syndr. 2012.PMID:23011399Free PMC article.
- The medicinal use of cannabis in the UK: results of a nationwide survey.Ware MA, Adams H, Guy GW.Ware MA, et al.Int J Clin Pract. 2005 Mar;59(3):291-5. doi: 10.1111/j.1742-1241.2004.00271.x.Int J Clin Pract. 2005.PMID:15857325
- Medical marijuana in HIV-positive patients: what do we know?Cinti S.Cinti S.J Int Assoc Physicians AIDS Care (Chic). 2009 Nov-Dec;8(6):342-6. doi: 10.1177/1545109709351167.J Int Assoc Physicians AIDS Care (Chic). 2009.PMID:19952287Review.
- In the weeds: a baseline view of cannabis use among legalizing states and their neighbours.Pacula RL, Jacobson M, Maksabedian EJ.Pacula RL, et al.Addiction. 2016 Jun;111(6):973-80. doi: 10.1111/add.13282. Epub 2016 Jan 26.Addiction. 2016.PMID:26687431Free PMC article.Review.
Cited by
- Prevalence, reasons, perceived effects, and correlates of medical marijuana use: A review.Park JY, Wu LT.Park JY, et al.Drug Alcohol Depend. 2017 Aug 1;177:1-13. doi: 10.1016/j.drugalcdep.2017.03.009. Epub 2017 May 16.Drug Alcohol Depend. 2017.PMID:28549263Free PMC article.Review.
- Representativeness of an HIV cohort of the sites from which it is recruiting: results from the Ontario HIV Treatment Network (OHTN) cohort study.Raboud J, Su D, Burchell AN, Gardner S, Walmsley S, Bayoumi AM, Blitz S, Cooper C, Salit I, Cohen J, Rourke SB, Loutfy MR.Raboud J, et al.BMC Med Res Methodol. 2013 Mar 5;13:31. doi: 10.1186/1471-2288-13-31.BMC Med Res Methodol. 2013.PMID:23496868Free PMC article.
- Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms.Bonn-Miller MO, Oser ML, Bucossi MM, Trafton JA.Bonn-Miller MO, et al.J Behav Med. 2014 Feb;37(1):1-10. doi: 10.1007/s10865-012-9458-5. Epub 2012 Oct 7.J Behav Med. 2014.PMID:23054178
- Differences in behavioral health disorders and unmet treatment needs between medical marijuana users and recreational marijuana users: Results from a national adult sample.Park JY, Wu LT.Park JY, et al.Drug Alcohol Depend. 2017 Nov 1;180:311-318. doi: 10.1016/j.drugalcdep.2017.08.028. Epub 2017 Sep 14.Drug Alcohol Depend. 2017.PMID:28942288Free PMC article.
- HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data).Barré T, Mercié P, Lions C, Miailhes P, Zucman D, Aumaître H, Esterle L, Sogni P, Carrieri P, Salmon-Céron D, Marcellin F; ANRS CO13 HEPAVIH Study Group.Barré T, et al.AIDS Res Ther. 2022 Mar 15;19(1):15. doi: 10.1186/s12981-022-00440-9.AIDS Res Ther. 2022.PMID:35292069Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical